Korea United Pharm Inc
KRX:033270

Watchlist Manager
Korea United Pharm Inc Logo
Korea United Pharm Inc
KRX:033270
Watchlist
Price: 20 550 KRW -1.44%
Market Cap: 302.3B KRW
Have any thoughts about
Korea United Pharm Inc?
Write Note

Korea United Pharm Inc
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Korea United Pharm Inc
Net Income Peer Comparison

Comparables:
000100
326030
008930
128940
S
000250

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Korea United Pharm Inc
KRX:033270
Net Income
â‚©32.2B
CAGR 3-Years
7%
CAGR 5-Years
1%
CAGR 10-Years
9%
Yuhan Corp
KRX:000100
Net Income
â‚©145.9B
CAGR 3-Years
16%
CAGR 5-Years
28%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Net Income
-â‚©35.4B
CAGR 3-Years
48%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Science Co Ltd
KRX:008930
Net Income
â‚©116.8B
CAGR 3-Years
56%
CAGR 5-Years
44%
CAGR 10-Years
17%
Hanmi Pharm Co Ltd
KRX:128940
Net Income
â‚©207.2B
CAGR 3-Years
87%
CAGR 5-Years
35%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Net Income
â‚©723.7m
CAGR 3-Years
N/A
CAGR 5-Years
-46%
CAGR 10-Years
-24%

See Also

What is Korea United Pharm Inc's Net Income?
Net Income
32.2B KRW

Based on the financial report for Jun 30, 2024, Korea United Pharm Inc's Net Income amounts to 32.2B KRW.

What is Korea United Pharm Inc's Net Income growth rate?
Net Income CAGR 10Y
9%

Over the last year, the Net Income growth was -33%. The average annual Net Income growth rates for Korea United Pharm Inc have been 7% over the past three years , 1% over the past five years , and 9% over the past ten years .

Back to Top